Member Info for smythsmoneybox

Odd this one, they are taking on a lot of staff in Belfast and sub contractors are also taking on a lot of staff. I know 4 that have left jobs to go work for them as the wages/terms are better.

I pencil, thanks for your contribution on this issue.

Can you help me understand this issue please.

Ive several more senior members of society who have been asking about the tracker funds.

Are they compelled to buy?

If so how much/ many %?

Are they able to buy & sell at will?

I cannot advise them as I'm unsure of the inn's & outta. They want to increase their already 6 figure holdings.

Thanks in advance

It won't be a director, stop being silly. Where is "the decent buys"? What director is going to embarras themselves buying stock on a Monday morning?

Jessiredd, "some posts here are just silly"

Your not long enough invested in Sheild to understand, if your invested at all.

They tried to go it alone in USA 2-3 years ago & failed so not "just entering" as you state.

Millions in revenue but more millions in losses, it ain't hard understand.

Cash flow positive also means we only bring in a little more than we spend, so at best 2025 we will gave a little profit but not enough to pay the bills. However thd "cashflow positive" goalposts are on wheels as they move, but you ain't here 4 years & wouldn't understand. But the market understands that, the market also understands when their taken for a ride.

Why has no director or institution filled their boots at 1.5 pence if this is such a great buisness?

The product maybe good but the management has been shocking .

HarChris, LWHL & I have been telling the idiot rampers the truth but you choose to keep the blindfold on.

Why do a few of us post facts? Ill tell you, we are here so long to have seen the management fundraise after fundraise, missed targets, economical with the truth.

DYOR & Goodluck all as we need it & more.

What does the longterm outlook look like?

It's very different from a realists perspective

HarChris has hit the bail on the head once again.

RIZ29, we all know your game, many like you have come before then suddenly dissappear. You can ramp to the cow's come but it doesn't change the facts. SWK are the king makers here, not forgetting that AOP might be up to something.

A 1% rise in prescriptions Q on Q isn't going to cut it.

You've showed your hand as a ramping clown.

No one has ever doubted the product -the product is not the issue.

The issue is the frame to profitability before dilution leaves us with nothing.

Are you working for sheild in some capacity?

Your on the watch list.

Jessiredd.

You seem to miss the elephant in the room. SWK.

What research have you done?

How long are you invested in STK?

Have you read & completely dismissed what SWK have set out as "minimum" targets, some have already been missed.

Do you know of all the fundraises?

Do you know that the goalposts are on wheels here they move so much?

A £1.50 fundraise & we are c 1.5 pennies, + all the much more recent raises.

In hospital terms, we are just been removed from life support, we are now in ICU but we may never get back to the ward. It's that simple.

Directors buying can be viewed in many ways for good or bad reasons. Directors not buying at this supposedly ridiculous cheap price tells its own story.

Have a great day GLA, DYOR

Optrade.......so it didnt "rocket" or go red.

Your a prize clown.

How long are you invested here?

They can all talk the talk, spin the spin but time will tell. They have as Harchris says told us all about Hardman research and lead us up the garden path. I've 2million of these at the wrong price & just glad today wasn't a total wipout but we are far far away from being out if the woods, but hey hoo, cash flow positive in H2 2025 apparently.....yes cash flow positive in H2 2025, I think he said H2 2025, correct me if I'm wrong but I do believe I heard both of them say H2 2025 but now my mind playing tricks with me. Was it H2 2025......that remains to be seen.....14 +months to wait

Once the market wakes up....catch a grip man.

Greg since arrival has presided over failure after failure. The goal posts keep getting moved and just expect another fund raise its probably priced in.

330k scripts in 2024,.....28.8k isn't actually a great start. If they get anywhere close to half that by year end it will be wonderful. However I doubt even that.

If good news is a 1% rise Q on Q I'd hate to see what bad news is.

GLA, ADYOR

Optrade,

do you actually believe all the figures and the targets will be reached.?

They have been circa 50% of any target set previously so will it suddenly all change?

Good luck in your belief this will rocket today....lol

if it closes blue it will be fantastic

I dare to dream that your statement might come true. However I'm long enough here to realise that they burn through cash, do not have a great sales record across Europe, delays in China, Korea.

No mention in results about other parts of the world.

Against Hardmans research of 65k, 28.8 is more than 50% of target. And a hell off a way of 45k, as a said before we need a complete step change in the company & we didn't get it.

Shocking....

£1.2 million for Europe, its time to cut ties & get a new partner. Look at the size of Germany, France, Spain, etc and all we can get us 1.2 million.

A shambles in Texas wiping out gains elsewhere.

A big boast about a 310% increase when in actual fact you missed your own revised down target by 40%.

Certainly not the greatest set of results but better than expected, and nothing to write home and tell your granny about & really nothing to be proud of.

"too big to fail" what a load of *******s, go and research "connaught" for actual proof that no one is too big to fail.

connaught had 20000 employees and a new ceo who bought £500k in share 2 weeks earlier and it went to the wall.

always dyor and don't listen to those online spouting an agenda one way or the other.

Results!

Who things thats the results will be stunning & shock us all in a good way?.

Just remember its this management that have missed targets, breached promises, fund raises at 30p, 15p and 6p who would actually believe a thing they say?

I understand we had an alleged pandemic which basically closed Sheilds marketplace for several years.

Before that this management team thought they could go and conquer the USA alone and that went tits up. How in anyone's mind thought it would be a good idea to take this drug into the states and hope to crack it? Eventually after lost time, effort & money did someone see sence and go 50/50 with a partner.

The list of shambolic management decisions is appalling.

Can the management pull a rabbit out of the hat?

In all honesty, I hope so buf doubt it.

GLA, DYOR & have a great weekend

Neon,

That's it, there or thereabouts as far as we will ever know.

There must be a total step change in company spend verses revenue intake for sheild to stay in ICU & not moved to the mortuary for buriel.

Flurry of buys....lol.

The poor people 6p will be so excited they'll be opening wine all weekend

What does your last post actually mean

If its in regards to future endorsement of shields only current drug,

you will see that China has no approval as yet and its 6 months late currently

What revenue comes from Canada?

Likewise Korea?

What are the many more catalysts?